Sign in

CIK 0001095981

  • Non-accelerated filer
  • Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330827593
Phone
+1 737-255-7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Exercise or conversion Chief Financial Officer acquired 67,452 shares (option exercise)
  6. 4 Exercise or conversion Chief Executive Officer acquired 201,632 shares (option exercise)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Exercise or conversion Chief Executive Officer acquired 159,681 shares (option exercise)
  11. 4 Exercise or conversion Chief Financial Officer acquired 38,323 shares (option exercise)
  12. 4 Open-market buy Chief Financial Officer bought 20,000 shares at $0.51 ($10,200)
  13. 4 Exercise or conversion Chief Executive Officer acquired 159,681 shares (option exercise)
  14. 4/A Derivatives Options or other derivatives
  15. 4 Exercise or conversion Chief Financial Officer acquired 38,323 shares (option exercise)
  16. 4/A Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 110,000 shares at $0.49 ($53,779)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 30 · 592 filings